Researchers uncover the genetic diversity of relapse in T-cell Acute Lymphoblastic Leukaemia June 02, 2025 Researchers uncover the genetic diversity of relapse in T-cell Acute Lymphoblastic Leukaemia
Registrations open for the Spetses Summer School 2022 “Cancer epigenetics: principles, applications and single-cell resolution” May 10, 2022 Registrations open for the Spetses Summer School 2022 “Cancer epigenetics: principles, applications and single-cell resolution”
Two birds with one stone: a refined bioinformatic analysis can estimate gene copy-number variations from epigenetic data May 10, 2022 Two birds with one stone: a refined bioinformatic analysis can estimate gene copy-number variations from epigenetic data
The Josep Carreras Leukaemia Research Institute, has been selected by the National Cancer Institute for the Cancer Proteome Project with the support of the Spanish Ministry of Science and Innovation May 06, 2022 The Josep Carreras Leukaemia Research Institute, has been selected by the National Cancer Institute for the Cancer Proteome Project with the support of the Spanish Ministry of Science and Innovation
Phase I of Europe's first self-produced CAR-T30 clinical trial for Hodgkin's and non-Hodgkin's lymphoma ends April 29, 2022 Phase I of Europe's first self-produced CAR-T30 clinical trial for Hodgkin's and non-Hodgkin's lymphoma ends
A Blood Test allows to differentiate severe COVID-19 from preeclampsia in pregnant women April 26, 2022 A Blood Test allows to differentiate severe COVID-19 from preeclampsia in pregnant women
Eulàlia Genescà and Francesc Solé: “We are taking real steps towards the implementation of the so-called personalized medicine” April 22, 2022 Eulàlia Genescà and Francesc Solé: “We are taking real steps towards the implementation of the so-called personalized medicine”
The Josep Carreras Leukaemia Research Institute and the Federació Empresarial de Badalona sign a collaboration agreement April 21, 2022 The Josep Carreras Leukaemia Research Institute and the Federació Empresarial de Badalona sign a collaboration agreement
Predicting response to adoptive cell therapies in cancer April 20, 2022 Predicting response to adoptive cell therapies in cancer
Josep Carreras Leukaemia Research Institute, new member of CataloniaBio & HealthTech April 19, 2022 Josep Carreras Leukaemia Research Institute, new member of CataloniaBio & HealthTech
The hidden cells behind B-cell acute lymphoblastic leukemia relapse spotlighted for the first time April 04, 2022 The hidden cells behind B-cell acute lymphoblastic leukemia relapse spotlighted for the first time
